Irhythm Technologies, INC 10-Q quarterly reports

iRhythm Holdings, Inc. announced a 20% increase in revenue for the second quarter of 2026, driven by higher patient service volumes, while also addressing a $45 million securities litigation settlement.

iRhythm Holdings reports strong Q1 2026 revenue growth of 26% to $199.4 million, driven by increased demand for its ambulatory cardiac monitoring services.

iRhythm Technologies reported a significant reduction in net loss and strong revenue growth for the third quarter and first nine months of 2025, driven by increased demand for its cardiac monitoring services.

iRhythm Technologies, a digital healthcare company, reported significant revenue growth and improved profitability for the second quarter and first half of 2025, despite facing multiple ongoing legal proceedings and regulatory scrutiny.

iRhythm Technologies' Q1 2025 revenue increased by 20% year-over-year, reaching $158.7 million, despite ongoing legal proceedings and regulatory scrutiny.

iRhythm Technologies' Q3 2024 results show a significant increase in revenue and strategic investments, alongside a net loss impacted by research and development expenses.

iRhythm Technologies' second quarter 2024 results show a 19% increase in revenue compared to the same period last year, driven by increased demand for their Zio Services.

iRhythm Technologies' first quarter 2024 results show a significant revenue increase of 18% compared to the same period last year, driven by higher demand for their Zio Services.